Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up

Rheumatology (Oxford). 2018 Aug 1;57(8):1494-1495. doi: 10.1093/rheumatology/key077.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Female
  • Follow-Up Studies
  • Humans
  • Interleukin-1beta
  • Male
  • Middle Aged
  • Pericarditis / drug therapy*
  • Pericarditis / etiology
  • Recurrence
  • Rheumatic Diseases / complications*
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Interleukin-1beta
  • canakinumab